NSG 533 EXAM 1 – 2026 WILKES ADVANCED
PHARMACOLOGY COMPLETE (110) CURRENT TESTING
QUESTIONS AND CORRECT ANSWERS WITH DETAILED
RATIONALES.
NSG
Prepare for the NSG 533 Exam 1 – Wilkes Advanced Pharmacology with this
comprehensive practice resource designed to strengthen your advanced
pharmacology knowledge and exam readiness. It features exam-style questions
covering foundational pharmacology principles, drug classifications, mechanisms of
action, pharmacokinetics, pharmacodynamics, medication safety, therapeutic
applications, and clinical prescribing concepts. Use it to reinforce essential concepts,
assess your understanding, and build confidence before test day. An excellent study
aid for Wilkes University nursing students preparing for the NSG 533 Advanced
Pharmacology Exam 1.
MULTIPLE CHOICE.
PHARMACOKINETICS, PHARMACODYNAMICS & FOUNDATIONS
(Questions 1–20)
Question 1: The geometric formula for the area of a triangle is:
A. (1/2)bh
B. πr²
C. 2πr
D. l × w
Correct answer: A. (1/2)bh
Rationale: The area of a triangle is calculated using (1/2) × base × height.
Question 2: The five essential components of pathophysiology are:
A. Etiology, Epidemiology, Pathogenesis, Clinical Manifestations, and
Outcomes
B. Etiology, Pathology, Symptoms, Diagnosis, and Treatment
C. Genetics, Environment, Lifestyle, Symptoms, and Prognosis
D. Etiology, Pathogenesis, Diagnosis, Treatment, and Prevention
, Page 2 of 36
Correct answer: A. Etiology, Epidemiology, Pathogenesis, Clinical
Manifestations, and Outcomes
Rationale: The five components of pathophysiology are: Etiology (causative
mechanisms), Epidemiology (risk factors and distribution in populations),
Pathogenesis (disease mechanism), Clinical Manifestations (signs,
symptoms, and diagnostic criteria), and Outcomes (cure, remission,
chronicity, or death).
Question 3: What is the primary mechanism of cell injury characterized by the
inability of the cell to produce adequate energy for its normal functions?
A. Free radical injury
B. ATP depletion
C. Calcium influx
D. Membrane permeability defects
Correct answer: B. ATP depletion
Rationale: ATP depletion is a common mechanism of cell injury where the
cell cannot produce adequate energy to fuel normal activities, often due to
hypoxia or ischemia.
Question 4: Which of the following is the most common method of impairing
oxygen and ATP production in cells?
A. Chemical injury
B. Radiation injury
C. Hypoxia
D. Genetic mutation
Correct answer: C. Hypoxia
Rationale: Hypoxia is the most common cause of impairing oxygen and ATP
production, leading to cell injury and death.
Question 5: Reactive oxygen species (ROS) are:
A. Chemically stable molecules that are beneficial to cells
B. Normal byproducts of cellular metabolism with an unpaired electron
C. Artificial compounds created only by pharmaceutical drugs
D. Antioxidants that protect cells from damage
, Page 3 of 36
Correct answer: B. Normal byproducts of cellular metabolism with an
unpaired electron
Rationale: Reactive oxygen species (ROS) are normal byproducts of cellular
metabolism during mitochondrial respiration. They are chemically reactive
molecules that can cause oxidative stress when produced in excess.
Question 6: A patient develops jaundice due to a hemolytic anemia. What
type of bilirubin predominates and what is the cause?
A. Conjugated bilirubin; defective excretion from liver cells
B. Unconjugated bilirubin; excessive breakdown of hemoglobin
C. Unconjugated bilirubin; obstruction of the bile duct
D. Conjugated bilirubin; failure of liver to uptake bilirubin
Correct answer: B. Unconjugated bilirubin; excessive breakdown of
hemoglobin
Rationale: In hemolytic jaundice, excessive breakdown of hemoglobin leads
to an overproduction of unconjugated bilirubin that exceeds the liver's
capacity to process it.
Question 7: Which of the following processes is characterized by organized,
programmed cell death without associated inflammation?
A. Necrosis
B. Apoptosis
C. Karyolysis
D. Pyknosis
Correct answer: B. Apoptosis
Rationale: Apoptosis is an organized, programmed process resulting in
elimination of individual cells. It is not associated with inflammation and may
be physiologic or pathologic.
Question 8: What is the significance of the Blood-Brain Barrier (BBB) in
pharmacotherapeutics?
A. It facilitates the absorption of oral medications
B. It limits the entry of many drugs into the central nervous system
C. It enhances the metabolism of neuroactive drugs
D. It promotes the excretion of hydrophilic drugs
, Page 4 of 36
Correct answer: B. It limits the entry of many drugs into the central
nervous system
Rationale: The Blood-Brain Barrier (BBB) restricts the passage of many
substances (including many drugs) from the blood into the brain, which is a
key consideration in CNS drug development and dosing.
Question 9: P-glycoprotein (P-gp) functions in the blood-brain barrier to:
A. Actively transport drugs into the brain
B. Actively efflux drugs out of the brain, limiting CNS penetration
C. Metabolize drugs within the brain
D. Produce cerebrospinal fluid
Correct answer: B. Actively efflux drugs out of the brain, limiting CNS
penetration
Rationale: P-gp is an ATP-dependent efflux transporter that pumps
substances (including many drugs) out of the brain and back into the blood.
Some drugs inhibit P-gp, increasing brain concentrations.
Question 10: A patient with impaired renal function would be expected to
have:
A. Decreased drug excretion and increased risk of toxicity
B. Increased drug excretion and decreased drug levels
C. No change in drug excretion
D. Decreased drug absorption
Correct answer: A. Decreased drug excretion and increased risk of
toxicity
Rationale: The kidney is the primary organ for drug excretion. Impaired renal
function reduces drug clearance, leading to drug accumulation and increased
risk of toxicity.
Question 11: A drug with a narrow therapeutic index requires:
A. Less frequent monitoring
B. Routine serum drug level monitoring
C. Higher doses for efficacy
D. Shorter half-life